Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that its industry-leading team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting .
- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that its industry-leading team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting .
- Charles River will present technology-driven capabilities and highlight the latest advancements in immuno-oncology, in vitro assays, and more.
- The meeting is taking place from April 5-10, 2024, at the San Diego Convention Center in San Diego, California.
- To learn more about Charles River’s research tools and services portfolio, visit booth #1121 at the AACR Annual Meeting 2024.